Carmen Monge-Montero: An important conversation on Neurodiversity and Cancer
Carmen Monge-Montero, Researcher and patient advocate at Youth Cancer Europe, reshared a post by European Network of Youth Cancer Survivors on LinkedIn, adding:
“Dear Network,
Join us next week for an important conversation on Neurodiversity and Cancer.
Neurodivergent individuals may experience cancer care in unique ways, facing challenges related to communication, sensory sensitivities, and medical navigation.
Together, we’ll explore how healthcare systems can be more inclusive and better support neurodivergent patients. Don’t miss this opportunity to learn and contribute to a more equitable cancer care experience!”
Quoting European Network of Youth Cancer Survivors‘s post:
“Did you know that 1 in 7 people are neurodivergent? How much do you know about neurodiversity and the many ways it can shape the patient’s experience
Join our “Neurodiversity & Cancer” webinar, we organise together with Youth Cancer Europe, to explore the experiences of people living with neurodiversity with and beyond cancer, and the challenges of navigating different healthcare systems.
From overwhelming sensory environments to communication barriers with medical teams, we’ll discuss how these factors impact patients’ overall well-being.
Date: 26th February 2025
Time: 5 PM CET
Online – Register here.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023